Is Climb Bio, Inc. (CLYM) a Buy, Sell, or Hold?
Climb Bio, Inc.
NASDAQ:CLYM
$13.87 USD
$0.63 (4.76%)
- Volume
- 969.59K
- Average Volume
- 1.19M
- Market Capitalization
- $945.72M
- P/E Ratio
- -17.78
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $14.42
- Year Low
- $1.36
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $27.86
CLYM vs. The Competition
| Properties | CLYM | ABOS | ACTU | AGEN |
|---|---|---|---|---|
| Market Cap | $945.72M | $134.47M | $41.15M | $208.63M |
| Shares Outstanding | $68.18M | $60.57M | $23.93M | $41.64M |
| P/E Ratio | -17.78 | -1.19 | -1.74 | 2.9 |
| EPS | -0.77 | -1.79 | -0.92 | 1.7 |
| Day Low | 12.75 | 2.205 | 1.6 | 4.655 |
| Day high | 13.99 | 2.54 | 1.73 | 5.19 |
| Year Low | 1.36 | 1.19 | 1.16 | 2.71 |
| Year High | 14.415 | 3.6 | 9.22 | 8.7 |
| Average Price 50 | 11.6805 | 2.4402 | 2.1315 | 3.4206 |
| Average Price 200 | 6.37423 | 2.32857 | 4.37918 | 3.6497 |
| Volume | 969.59K | 674.38K | 272.45K | 4.46M |
| Average Volume | - | - | - | - |